Header cover image

Singaporean (SGX) Healthcare Sector Analysis

UpdatedMar 27, 2023
DataAggregated Company Financials
Companies32
  • 7D-1.0%
  • 3M2.3%
  • 1Y-4.2%
  • YTD2.4%

Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by Thomson Medical Group declining 7.0%. However, the industry is down 4.1% over the past year. Earnings are forecast to grow by 12% annually.

Sector Valuation and Performance

Has the Singaporean Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Mar 2023S$13.0bS$4.4bS$630.8m15.2x20.6x2.9x
Wed, 22 Feb 2023S$13.9bS$4.4bS$647.2m16.3x21.4x3.2x
Fri, 20 Jan 2023S$13.2bS$4.4bS$679.5m15.4x19.4x3x
Sun, 18 Dec 2022S$12.8bS$4.4bS$678.1m15.6x18.9x2.9x
Tue, 15 Nov 2022S$13.1bS$4.4bS$670.3m14.5x19.5x3x
Thu, 13 Oct 2022S$12.0bS$4.5bS$731.3m14.4x16.4x2.7x
Sat, 10 Sep 2022S$13.3bS$4.5bS$739.2m15.8x18x2.9x
Mon, 08 Aug 2022S$13.4bS$4.7bS$887.4m15.4x15.1x2.8x
Wed, 06 Jul 2022S$12.9bS$4.7bS$980.6m15.2x13.1x2.7x
Fri, 03 Jun 2022S$13.0bS$4.9bS$1.1b14.6x11.7x2.7x
Sun, 01 May 2022S$22.7bS$4.9bS$1.1b14.6x20.5x4.6x
Tue, 29 Mar 2022S$14.1bS$5.0bS$1.1b14.8x12.5x2.8x
Thu, 24 Feb 2022S$14.2bS$5.1bS$1.2b15x11.7x2.8x
Sat, 22 Jan 2022S$14.5bS$5.1bS$1.2b14.7x12.1x2.8x
Mon, 20 Dec 2021S$14.2bS$5.1bS$1.2b14.8x11.8x2.8x
Wed, 17 Nov 2021S$14.5bS$5.1bS$1.2b16.2x12.1x2.8x
Fri, 15 Oct 2021S$15.3bS$5.1bS$1.2b14.8x13x3x
Sun, 12 Sep 2021S$15.7bS$5.0bS$1.2b16.3x13.4x3.1x
Tue, 10 Aug 2021S$16.7bS$5.0bS$1.2b15.3x14.2x3.3x
Mon, 03 May 2021S$16.4bS$4.7bS$912.4m17.7x18x3.5x
Thu, 04 Feb 2021S$13.3bS$4.3bS$651.7m20.7x20.4x3.1x
Sun, 08 Nov 2020S$12.9bS$3.9bS$494.4m18.2x26.2x3.3x
Sat, 01 Aug 2020S$13.4bS$3.6bS$385.0m18.4x34.9x3.7x
Tue, 05 May 2020S$10.3bS$3.6bS$475.9m15.8x21.6x2.9x
Price to Earnings Ratio

19.2x


Total Market Cap: S$9.2bTotal Earnings: S$480.5mTotal Revenue: S$3.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Singaporean Healthcare Sector Price to Earnings3Y Average 18.7x202120222023
Current Industry PE
  • Investors are optimistic on the Singaporean Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 20.7x which is higher than its 3-year average PE of 18.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 9.5% per year over the last three years.
  • Revenues for these companies have grown 6.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Singaporean Healthcare sector?

SG Market0.50%
Healthcare-1.05%
Medical Equipment3.35%
Healthtech0%
Biotech0%
Life Sciences0%
Healthcare Services-1.10%
Pharma-1.74%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 28.6x.
    • Analysts are expecting annual earnings growth of 0.8%, which is lower than the prior year's growth of 17.0% per year.
  • Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 9.1x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 23% over the next 5 years.
  • However this is lower than its past earnings growth rate of 35% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings decline by 5.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BSL Raffles Medical GroupS$1.435.1%
+S$129.9m
21.2%PE18.5x
AP4 Riverstone HoldingsS$0.589.4%
+S$74.1m
-40.8%PE9.1x
H02 Haw ParS$9.472.0%
+S$42.1m
-20.4%PE14.1x
546 Medtecs InternationalS$0.1321.2%
+S$12.0m
-42.7%PS0.9x
V8Y Quantum HealthcareS$0.00620.0%
+S$6.9m
0%PS3.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

QC7

S$0.32

Q & M Dental Group (Singapore)

7D

-4.5%

1Y

-41.1%

1D4

S$0.14

Aoxin Q & M Dental Group

7D

-4.1%

1Y

-20.6%

5NG

S$0.033

Healthway Medical

7D

-2.9%

1Y

0%

546

S$0.13

Medtecs International

7D

21.2%

1Y

-42.7%

P8A

S$0.32

Cordlife Group

7D

-1.5%

1Y

-20.0%

H02

S$9.47

Haw Par

7D

2.0%

1Y

-20.4%

AP4

S$0.58

Riverstone Holdings

7D

9.4%

1Y

-40.8%

40T

S$0.32

ISEC Healthcare

7D

-3.0%

1Y

6.7%

V8Y

S$0.006

Quantum Healthcare

7D

20.0%

1Y

0%

8K7

S$0.16

UG Healthcare

7D

3.8%

1Y

-33.5%

42C

S$0.081

iX Biopharma

7D

-2.4%

1Y

-56.0%

PRH

S$0.064

Livingstone Health Holdings

7D

25.5%

1Y

-56.5%